ESMO 2010: Cancer of unknown primary origin

3 Vues
administrator
administrator
07/10/23

Prof Nicholas Pavlidis speaks about the effects, prevalence and best ways of detecting and treating cancer of unknown primary origin (CUP). Prof Pavlidis stresses the importance of a correct diagnosis and explains the differences in treatment for CUP depending on the patient's prognosis.

Prof Nicholas Pavlidis of the University of Ioannina in Greece, speaking to ecancer.tv at the 2010 ESMO congress in Milan, Italy

  • Catégorie

Montre plus
0 commentaires Trier par

    Aucun commentaire trouvé

    Commentaires de Facebook

    Suivant

    Primary Treatment of Anal Cancer
    00:12:15
    Primary Treatment of Anal Cancer
    administrator
    4 Vues
    Management of Primary Bone Tumors - Ehud Mendel, MD, FACS
    00:35:39
    Management of Primary Bone Tumors - Ehud Mendel, MD, FACS
    administrator
    2 Vues
    Culture Of Primary Human Fallopian Tube Epithelial Cells l Protocol Preview
    00:02:01
    Culture Of Primary Human Fallopian Tube Epithelial Cells l Protocol Preview
    administrator
    3 Vues
    DTRF at Hazelwood Farm July 2010
    00:05:14
    DTRF at Hazelwood Farm July 2010
    administrator
    2 Vues
    DTRF at Hazelwood Farm #2_July 2010
    00:05:17
    DTRF at Hazelwood Farm #2_July 2010
    administrator
    2 Vues
    Primary Ewing Sarcoma of Fronto parietal Bone with Major Soft Tissue Extension
    00:05:06
    Primary Ewing Sarcoma of Fronto parietal Bone with Major Soft Tissue Extension
    administrator
    3 Vues
    ESMO 2018 - Ewing's sarcoma: the epigenetics route
    00:01:39
    ESMO 2018 - Ewing's sarcoma: the epigenetics route
    administrator
    0 Vues
    Primary Brain Tumors Commonly tested on the USMLE - USMLE to Residency
    00:15:36
    Primary Brain Tumors Commonly tested on the USMLE - USMLE to Residency
    administrator
    3 Vues
    Primary brain Tumors.
    00:33:11
    Primary brain Tumors.
    administrator
    3 Vues
    Cancer ‘cured’ in all patients in drug trial, Indian origin patient healed
    00:05:44
    Cancer ‘cured’ in all patients in drug trial, Indian origin patient healed
    administrator
    3 Vues
    Treatment outcomes from primary CTCL
    00:00:50
    Treatment outcomes from primary CTCL
    administrator
    2 Vues
    Answers from the Experts: What is Primary Cutaneous Anaplastic Large Cell Lymphoma?
    00:03:30
    Answers from the Experts: What is Primary Cutaneous Anaplastic Large Cell Lymphoma?
    administrator
    2 Vues
    Rare Variant: Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder (provisional)
    00:03:28
    Rare Variant: Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder (provisional)
    administrator
    3 Vues
    Rare Variant: Primary Cutaneous Peripheral T-cell Lymphoma (NOS)
    00:03:51
    Rare Variant: Primary Cutaneous Peripheral T-cell Lymphoma (NOS)
    administrator
    2 Vues
    Primary Cutaneous T-cell Lymphoma: ALCANZA Trial
    00:03:00
    Primary Cutaneous T-cell Lymphoma: ALCANZA Trial
    administrator
    1 Vues
    Post ESMO Webinar with Dr. Dummer: Skin Cancer News
    00:28:25
    Post ESMO Webinar with Dr. Dummer: Skin Cancer News
    administrator
    1 Vues
    What's New in Melanoma - Dr. Bartosz Chmielowski, MD | UCLA Primary Care Update 2015
    00:49:05
    What's New in Melanoma - Dr. Bartosz Chmielowski, MD | UCLA Primary Care Update 2015
    administrator
    3 Vues
    Survival Data for Patients Younger Than 60 With Primary Myleofibrosis
    00:06:03
    Survival Data for Patients Younger Than 60 With Primary Myleofibrosis
    administrator
    0 Vues
    Primary Myelofibrosis (PMF) | Myeloproliferative Neoplasm| Bone Marrow Fibrosis
    00:11:44
    Primary Myelofibrosis (PMF) | Myeloproliferative Neoplasm| Bone Marrow Fibrosis
    administrator
    4 Vues